Sask. vaccine developer locks in Canadian manufacturers for human clinical trials
Thursday, July 30, 2020 - 12:30
in Health & Medicine
The University of Saskatchewan has contracted two Canadian pharmaceutical companies to manufacture ingredients for its COVID-19 vaccine for the first stages of human clinical trials.